
Literature Values of Terminal Half-Lives of Clozapine are Dependent on the Time of the Last Data Point
Author(s) -
Jim Fang,
Karen E. Mosier
Publication year - 2014
Publication title -
journal of pharmacy and pharmaceutical sciences
Language(s) - English
Resource type - Journals
ISSN - 1482-1826
DOI - 10.18433/j3kc7p
Subject(s) - clozapine , terminal (telecommunication) , pharmacokinetics , therapeutic window , drug , medicine , end point , pharmacology , psychology , psychiatry , schizophrenia (object oriented programming) , computer science , telecommunications , real time computing
The pharmacokinetics of clozapine is a subject of intensive research because of its narrow therapeutic window and susceptibility to drug-drug interactions. A systematic literature search was conducted in PubMed and Google Scholar for half-life values of clozapine in humans. Twenty-one publications were found to contain terminal half-life information of clozapine in humans along with the time of the last plasma sample. Average values of the terminal half-lives of clozapine were calculated to be 10.2, 13.2, 14.2, 18.3 and 29.2 hours with a last data point at 12, 24, 48, 72 and 120 hours, respectively. This confirms the notion that one would arrive at longer terminal half-lives when longer blood sampling times are used in pharmacokinetic studies on clozapine. “Terminal half-lives” of therapeutic agent are routinely computed and reported in literature. For drugs with a third deep compartment such as clozapine, one should remember to consider the time of the last data point when comparing the “terminal” half-life.